Key Highlights
- Pharmavite LLC acquires Bonafide Health, marking a significant expansion in its women’s health division.
- Bonafide Health’s focus on menopause management complements Pharmavite’s existing brands, including Uqora and Equelle.
- The acquisition enhances Pharmavite’s position as a leader in women’s health nutraceuticals, backed by science and innovation.
Source: Business Wire
Notable Quotes
- “We’re thrilled to welcome Bonafide Health to Pharmavite. This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this underserved space.” – Jeff Boutelle, CEO at Pharmavite
- “Our steadfast commitment to science and innovation has allowed us to build something special at Bonafide Health and we’ve been looking for the right partner to grow the business and reach more women that need support. Pharmavite is that partner.” – Michael Satow, Co-Founder and CEO at Bonafide Health
SoH's Take
The acquisition of Bonafide Health by Pharmavite LLC is a strategic move that signifies a growing focus on women’s health, particularly in the area of menopause management. This move not only strengthens Pharmavite’s position in the market but also highlights the increasing importance of science-backed, innovative solutions in the nutraceutical industry. By integrating Bonafide’s robust product lineup and scientific approach with its own, Pharmavite is poised to address a broader range of women’s health needs, underscoring its commitment to wellness and health education. This acquisition is a clear indicator of the evolving dynamics in the health and wellness sector, where consumer needs are driving innovation and expansion.
